Redmond-based medical device company EchoNous has named longtime ultrasound executive Graham Cox as its CEO.
Cox, who was announced as CEO on Tuesday, replaces Kevin Goodwin, who co-founded the company in 2016. Goodwin retired at the end of last year, and Cox had served as interim CEO before the board made the appointment permanent, a spokesperson for the company said.
“EchoNous is poised for success, and I am honored to lead this talented team as we continue to break new ground,” Cox said in a news release.
Cox has more than 40 years of experience in the ultrasound industry, according to EchoNous. He joined EchoNous in 2020, according to his LinkedIn profile, and served as chief commercial officer of the company before taking the CEO role. He spent more than 12 years at the ultrasound company Fujifilm Sonosite earlier in his career.
EchoNous makes handheld ultrasound tools for monitoring the heart, stomach, lungs and nerves, among other uses. The company also makes software to supplement its medical devices. According to EchoNous, the company uses artificial intelligence to guide medical professionals using its ultrasound devices.
EchoNous raised a $57 million Series D round in September and a $60 million round in 2021. New York City-based credit manager Kennedy Lewis led both rounds. EchoNous added $30 million to its Series D round, its spokesperson said.
Goodwin co-founded Sonosite in 1998 before launching EchoNous. Fujifilm Holdings Corp. acquired Sonosite for $995 million in 2011.
“We have a technology platform that I think has tremendous long-term implications for medicine, let alone ultrasound in medicine,” Goodwin told the Business Journal in 2021. “And the reason for that is we've extremely miniaturized a very high-quality, high-performance ultrasound device into an 8-ounce package. So basically we've reached a frontier in terms of silicon chip integration of ultrasound circuitry.”
